Eurofirst News: Eurofirst 100, Eurofirst 250, and Eurofirst 500 investment news
Eurofirst market news from the Euronext Stock Exchange: Eurofirst 100, Eurofirst 250, and Eurofirst 400

Latest Eurofirst News:

  • European carmakers higher on Nissan gains

  • IBEX adds 1.42 percent on session

  • France Telecom gains over 8.5 percent on results

  • Banks see declines in Europe

  • European equities lower on renewed subprime worries

  • IBEX gains again amid European equities declines

  • Truck maker Man up on bids rumors

  • IBEX gains almost 1 percent on session

  • European utilities gain again

  • European equities lower on session

  • Euronext news feed


    Recommended equities news sites

  • Euronext
  • Euro Watch
  • FTSE News
  • Tokyo Market News
  • NYSE News
  • Mortgages & Loans
  •  

    January 11, 2007

    EADS gains despite broker downgrade

    Filed under: Roche, Euronext, Deutsche Borse, Banco Santander Central Hispano, Swedbank, EADS, Banco Bilbao Vezcaya Argentaria

    The FTSE Eurofirst 300 was up significantly on Thursday, adding 1.8 percent to close the session at 1,503.93.

    Banks were higher on bids rumors and broker comments. After Dresdner Kleinwort implied that there was a possibility of merger activity in the Spanish banking sector, Santander and BBVA were both higher. Santander added 1.3 percent to €14.30, while BBVA gained 1.7 percent to €18.73. Swedbank as 5.2 percent higher to SKr262.50 when UBS repeated its “buy” recommendation and upped its target share price from SKr265 to SKr300.

    Stock exchanges also did well on the session. Euronext added 3.8 percent to €98.50 on approval of its plans to merge with the New York Stock Exchange. Meanwhile, Deutsche Borse gained 6.3 percent to €150.20 on talk that it could also merge with an exchange operator in the US. The Chicago Mercantile Exchange has been mentioned as a possible merger partner.

    Roche was 2 percent higher to SFr230.70 on higher profits in the fourth quarter by Genentech, in which the Swiss pharmaceutical company is majority stockholder. Genentech’s fourth quarter profits were up 75 percent on demand for its cancer drugs and higher sales of a new treatment for blindness in older patients.

    In the aerospace sector, EADS added 0.8 percent to €25.26 even though UBS reduced its recommendation from “neutral” to “sell” and warned that shareholders earnings could be diluted by a possible equity issue by the company.





    Latest Equities News:

  • Europe, US, most Asia markets lower on news, data

  • Equities decline globally on European debt concerns

  • Most global equities markets see declines on commodities prices

  • Europe, Asia markets mixed as Wall Street declines

  • European, US markets see gains as Asia markets remain mixed

  • European equities decline on lower credit rating for Greece

  • European equities markets gain, helped by US jobs report

  • Most global equities markets in decline

  • Europe, US, Asia markets all see declines

  • London markets see gains as most European markets retreat

  • Eurofirst News copyright 2012 Central Consultants